SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-22-006588
Filing Date
2022-02-24
Accepted
2022-02-24 16:45:44
Documents
2
Period of Report
2022-02-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 1470
2 EXHIBIT 24 brhc10034432_ex24.htm EX-24 3821
  Complete submission text file 0001140361-22-006588.txt   6833
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Issuer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELLECTAR BIOSCIENCES, INC. 3301 AGRICULTURE DRIVE MADISON WI 53716
Business Address
Kolean Chad J (Reporting) CIK: 0001616753 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36598 | Film No.: 22671875